Back to Journals » Clinical Epidemiology » Volume 12

Excess Body Weight and Incidence of Type 1 and Type 2 Endometrial Cancer: The Norwegian Women and Cancer Study

Authors Sollberger TL, Gavrilyuk O, Rylander C

Received 14 March 2020

Accepted for publication 5 June 2020

Published 31 July 2020 Volume 2020:12 Pages 815—824

DOI https://doi.org/10.2147/CLEP.S253866

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Irene Petersen


Tanja Lise Sollberger,1 Oxana Gavrilyuk,2 Charlotta Rylander3

1Department of Anesthesiology, University Hospital of North Norway, Tromsø, Norway; 2Department of Clinical Oncology, Norwegian Radium Hospital, Oslo, Norway; 3Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway

Correspondence: Charlotta Rylander
Department of Community Medicine, UiT the Arctic University of Norway, Tromsø 9037, Norway
Tel +47 77644831
Email charlotta.rylander@uit.no

Purpose: Excess body weight has been associated with increased risk of 13 cancer types and is a particularly strong risk factor for endometrial cancer (EC). Only a few previous studies have assessed the relationship between excess body weight and EC subtypes. In this study, we aimed to investigate the associations between excess weight and incidence of type 1 and type 2 EC.
Patients and Methods: We used data from 151,537 participants in the Norwegian Women and Cancer (NOWAC) cohort of which 935 were diagnosed with type 1 and 263 with type 2 EC during follow-up. Height and body weight were self-reported. Multivariable Cox proportional hazard regression was used to assess the associations between body mass index (BMI) and type 1 and type 2 EC.
Results: For every 2 kg/m2 increase in BMI, the risk of type 1 EC increased by 21% (HR=1.21, 95% CI: 1.18, 1.24) and the risk of type 2 EC by 10% (HR=1.10, 95% CI: 1.03, 1.16) (pheterogeneity = 0.009). During the period 1991 to 2016, 24.0% (95% CI: 20.0% to 27.8%) of type 1 EC cases was attributable to excess body weight. Avoiding obesity could have prevented 6.6% (95% CI: 3.4% to 9.7%) of type 2 EC cases.
Conclusion: Excess body weight was associated with both type 1 and type 2 EC in a dose-dependent manner and the association was significantly stronger in type 1 EC. These findings could support the hypothesis that estrogen plays a more important role in the development of type 1 ECs than in type 2 EC.

Keywords: obesity, overweight, cancer of the corpus uteri, uterus cancer, subtypes, body fatness

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]